Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors

BB Healthcare Trust expects stock-specific fundamentals to hold sway in the sector in the second half

"Valuations look undemanding in a number of healthcare sub-sectors and the need for healthcare products and services will continue to grow into the foreseeable future," said Professor Justin Stebbin, the trust's chairman
Drugs in a container
"Drug stocks and the wider drug supply chain have been whipsawed by the twin spectres of Trump-driven pricing reform and Amazon-induced obsolescence"

BB Healthcare Trust PLC (LON:BBH) said the six months to the end of May had been another period of positive progress.

During the period, the company's share price and net asset value (NAV) recorded total returns in sterling terms of 4.0% and 7.5% respectively.

READ: BB Healthcare Trust delivers as it comfortably beats its benchmark

In comparison, the MSCI World Healthcare Index (in sterling terms) delivered a total return of 1.7%.

In the period since the trust was set up to 31 May 2018, the company's share price and NAV have delivered total returns in sterling terms of 25.3% and 26.0% respectively, versus a total return of 16.4% on the MSCI World Healthcare Index.

The chairman, Professor Justin Stebbing, said the first half of 2018 saw a continuation of the volatile macro-political environment that characterised the prior year, making a difficult climate for equity investors.

The healthcare sector, which is the trust's area of focus, “has again been caught up in US polemics”, Stebbing said.

“With mid-term electioneering in full swing, sentiment is unlikely to improve markedly in the near-term. In such a context, allied to the fading earnings power of the large pharmaceutical companies that account for almost half the benchmark value in the quoted sector, it is not a surprise that healthcare underperformed the MSCI World Index by 1.6% during the period,” Stebbing noted.

In spite of the sector's lacklustre performance over the period, the trust's management remains very optimistic regarding the investment return opportunity in healthcare.

The BB chairman predicted a pivot back toward stock-specific fundamentals in the second half of the year.

Shares in BB Healthcare currently trade at 132p, a shade above the NAV of 130.9p, as at July 10.

View full BBH profile View Profile

BB Healthcare Trust PLC Timeline

Big Picture
February 14 2018

Related Articles

trading screen
February 14 2018
Chairman, Professor Justin Stebbing, said he hoped 2018 would be driven more by stock fundamentals

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use